346 related articles for article (PubMed ID: 26417704)
1. Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis.
Corvol H; Blackman SM; Boëlle PY; Gallins PJ; Pace RG; Stonebraker JR; Accurso FJ; Clement A; Collaco JM; Dang H; Dang AT; Franca A; Gong J; Guillot L; Keenan K; Li W; Lin F; Patrone MV; Raraigh KS; Sun L; Zhou YH; O'Neal WK; Sontag MK; Levy H; Durie PR; Rommens JM; Drumm ML; Wright FA; Strug LJ; Cutting GR; Knowles MR
Nat Commun; 2015 Sep; 6():8382. PubMed ID: 26417704
[TBL] [Abstract][Full Text] [Related]
2. A flexible summary statistics-based colocalization method with application to the mucin cystic fibrosis lung disease modifier locus.
Wang F; Panjwani N; Wang C; Sun L; Strug LJ
Am J Hum Genet; 2022 Feb; 109(2):253-269. PubMed ID: 35065708
[TBL] [Abstract][Full Text] [Related]
3. Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci.
Gong J; Wang F; Xiao B; Panjwani N; Lin F; Keenan K; Avolio J; Esmaeili M; Zhang L; He G; Soave D; Mastromatteo S; Baskurt Z; Kim S; O'Neal WK; Polineni D; Blackman SM; Corvol H; Cutting GR; Drumm M; Knowles MR; Rommens JM; Sun L; Strug LJ
PLoS Genet; 2019 Feb; 15(2):e1008007. PubMed ID: 30807572
[TBL] [Abstract][Full Text] [Related]
4. Genetic Modifiers of Cystic Fibrosis Lung Disease Severity: Whole-Genome Analysis of 7,840 Patients.
Zhou YH; Gallins PJ; Pace RG; Dang H; Aksit MA; Blue EE; Buckingham KJ; Collaco JM; Faino AV; Gordon WW; Hetrick KN; Ling H; Liu W; Onchiri FM; Pagel K; Pugh EW; Raraigh KS; Rosenfeld M; Sun Q; Wen J; Li Y; Corvol H; Strug LJ; Bamshad MJ; Blackman SM; Cutting GR; Gibson RL; O'Neal WK; Wright FA; Knowles MR
Am J Respir Crit Care Med; 2023 May; 207(10):1324-1333. PubMed ID: 36921087
[No Abstract] [Full Text] [Related]
5. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
6. Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis.
Dorfman R; Taylor C; Lin F; Sun L; Sandford A; Paré P; Berthiaume Y; Corey M; Durie P; Zielenski J;
Pediatr Pulmonol; 2011 Apr; 46(4):385-92. PubMed ID: 20967843
[TBL] [Abstract][Full Text] [Related]
7. Detection of modifier loci influencing the lung phenotype of cystic fibrosis knockout mice.
Haston CK; McKerlie C; Newbigging S; Corey M; Rozmahel R; Tsui LC
Mamm Genome; 2002 Nov; 13(11):605-13. PubMed ID: 12461645
[TBL] [Abstract][Full Text] [Related]
8. Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis.
Ruffin M; Mercier J; Calmel C; Mésinèle J; Bigot J; Sutanto EN; Kicic A; Corvol H; Guillot L
Cell Mol Life Sci; 2020 Sep; 77(17):3311-3323. PubMed ID: 32166393
[TBL] [Abstract][Full Text] [Related]
9. Regulatory dynamics of 11p13 suggest a role for EHF in modifying CF lung disease severity.
Stolzenburg LR; Yang R; Kerschner JL; Fossum S; Xu M; Hoffmann A; Lamar KM; Ghosh S; Wachtel S; Leir SH; Harris A
Nucleic Acids Res; 2017 Sep; 45(15):8773-8784. PubMed ID: 28549169
[TBL] [Abstract][Full Text] [Related]
10. Modifier genes in cystic fibrosis lung disease.
Merlo CA; Boyle MP
J Lab Clin Med; 2003 Apr; 141(4):237-41. PubMed ID: 12677168
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms associated with expression of BPIFA1/BPIFB1 and lung disease severity in cystic fibrosis.
Saferali A; Obeidat M; Bérubé JC; Lamontagne M; Bossé Y; Laviolette M; Hao K; Nickle DC; Timens W; Sin DD; Postma DS; Strug LJ; Gallins PJ; Paré PD; Bingle CD; Sandford AJ
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):607-14. PubMed ID: 25574903
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2.
Wright FA; Strug LJ; Doshi VK; Commander CW; Blackman SM; Sun L; Berthiaume Y; Cutler D; Cojocaru A; Collaco JM; Corey M; Dorfman R; Goddard K; Green D; Kent JW; Lange EM; Lee S; Li W; Luo J; Mayhew GM; Naughton KM; Pace RG; Paré P; Rommens JM; Sandford A; Stonebraker JR; Sun W; Taylor C; Vanscoy LL; Zou F; Blangero J; Zielenski J; O'Neal WK; Drumm ML; Durie PR; Knowles MR; Cutting GR
Nat Genet; 2011 Jun; 43(6):539-46. PubMed ID: 21602797
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity.
Kormann MSD; Dewerth A; Eichner F; Baskaran P; Hector A; Regamey N; Hartl D; Handgretinger R; Antony JS
PLoS One; 2017; 12(8):e0183526. PubMed ID: 28846703
[TBL] [Abstract][Full Text] [Related]
14. Genetic Variation Near chrXq22-q23 Is Linked to Emotional Functioning in Cystic Fibrosis.
Barbato E; Daly B; Douglas S; Kerr M; Litman P; Darrah R
Biol Res Nurs; 2020 Jul; 22(3):319-325. PubMed ID: 32390518
[TBL] [Abstract][Full Text] [Related]
15. Lung disease modifier genes in cystic fibrosis.
Guillot L; Beucher J; Tabary O; Le Rouzic P; Clement A; Corvol H
Int J Biochem Cell Biol; 2014 Jul; 52():83-93. PubMed ID: 24569122
[TBL] [Abstract][Full Text] [Related]
16. Mining GWAS and eQTL data for CF lung disease modifiers by gene expression imputation.
Dang H; Polineni D; Pace RG; Stonebraker JR; Corvol H; Cutting GR; Drumm ML; Strug LJ; O'Neal WK; Knowles MR
PLoS One; 2020; 15(11):e0239189. PubMed ID: 33253230
[TBL] [Abstract][Full Text] [Related]
17. Update on gene modifiers in cystic fibrosis.
Collaco JM; Cutting GR
Curr Opin Pulm Med; 2008 Nov; 14(6):559-66. PubMed ID: 18812833
[TBL] [Abstract][Full Text] [Related]
18. CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severity.
Blaisdell CJ; Howard TD; Stern A; Bamford P; Bleecker ER; Stine OC
BMC Med Genet; 2004 Oct; 5():26. PubMed ID: 15507145
[TBL] [Abstract][Full Text] [Related]
19. Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis.
Choi EH; Ehrmantraut M; Foster CB; Moss J; Chanock SJ
Pediatr Pulmonol; 2006 Mar; 41(3):255-62. PubMed ID: 16429424
[TBL] [Abstract][Full Text] [Related]
20. Mucin variable number tandem repeat polymorphisms and severity of cystic fibrosis lung disease: significant association with MUC5AC.
Guo X; Pace RG; Stonebraker JR; Commander CW; Dang AT; Drumm ML; Harris A; Zou F; Swallow DM; Wright FA; O'Neal WK; Knowles MR
PLoS One; 2011; 6(10):e25452. PubMed ID: 21998660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
